Quantification of neurofilament light and glial fibrillary acidic protein in finger-prick blood.
Ontology highlight
ABSTRACT: An accurate diagnosis of neurodegenerative disease and traumatic brain injury is important for prognostication and treatment. Neurofilament light and glial fibrillary acidic protein (GFAP) are leading biomarkers for neurodegeneration and glial activation that are detectable in blood. Yet, current recommendations require rapid centrifugation and ultra-low temperature storage post-venepuncture. Here, we investigated if these markers can be accurately measured in finger-prick blood using dried plasma spot cards. Fifty patients (46 with dementia; 4 with traumatic brain injury) and 19 healthy volunteers underwent finger-prick and venous sampling using dried plasma spot cards and aligned plasma sampling. Neurofilament light and GFAP were quantified using a Single molecule array assay and correla
SUBMITTER: Kolanko MA
PROVIDER: S-EPMC11189302 | biostudies-literature | 2024
REPOSITORIES: biostudies-literature
ACCESS DATA